期刊文献+

复方肝毒清对免疫性肝损伤模型小鼠的保护作用 被引量:5

Protective Effect of Compound Ganduqing on Mice Liver Injury Induced by Concanavalin A
下载PDF
导出
摘要 [目的]观察复方肝毒清对刀豆蛋白A(ConA)所致小鼠肝损伤的保护作用。[方法]昆明种小鼠60只,随机分为空白对照组,模型对照组,肝毒清高、中、低剂量组(20、10、5g/kg),联苯双酯组(150mg/kg);除空白对照组外,所有小鼠2次尾静脉注射ConA(20mg/kg)复制肝损伤模型,各组均按设计剂量灌胃给药,空白对照组和模型对照组给予等容积生理盐水,共给药3次;取血清检测谷丙转氨酶(ALT)、肿瘤坏死因子-α(TNF-α),取肝组织检测TNF-αmRNA表达,并进行肝组织病理学检查。[结果]肝毒清高、中、低剂量组均能降低血清ALT、TNF-α水平,抑制肝组织TNF-αmRNA表达,与模型对照组比较具有显著性差异(均P<0.01),并能一定程度改善肝组织病理变化。[结论]复方肝毒清对ConA所致小鼠肝损伤具有一定的保护作用。 [Objective] To observe the protective effect of the Compound Ganduqing (CG) on mice liver injury induced by concanavalin A (ConA) . [Methods] Sixty Kunming mice were randomly divided into six groups: blank control group (group A), model group (group B), 150 mg/kg biphenyldicarboxylate group (group C), 20g/kg CG group (group D), 10 g/kg CG group (group E), and 5 g/kg CG group (group F). Except the blank control group, the mice were administered with injection of ConA, bid, into the caudal vein to establish liver injury models and then were administered by gavage according to the experiment design. The blank control and model groups were given the same dose of saline, tid. After treatment, serum alanine aminotransferase (ALT) and tumor necrosis factor (TNF-α) levels, TNF-α mRNA expression in the liver tissue and hepatic pathological changes were tested. [Results] Compared with the model group, CG in three dosages markedly depressed serum levels of ALT and TNF-α, inhibited TNF-α mRNA expression (P < 0.01) and improved hepatic pathological features. [ Conclusion ] CG has a protective effect on mice liver injury induced by ConA.
出处 《广州中医药大学学报》 CAS 2005年第4期285-288,共4页 Journal of Guangzhou University of Traditional Chinese Medicine
关键词 复方肝毒清/药理学 肝炎 乙型/中药疗法 肝/损伤 肝/病理学 疾病模型 动物 小鼠 COMPOUND GANDUQING/pharmacology HEPATITIS, TYPE B/TCD therapy LIVER/injuries LIVER/pathology DISEASE MODELS, ANIMAL MICE
  • 相关文献

参考文献11

  • 1何金洋,郭兴伯,朱宇同,李向阳,周红燕,赵昉.复方肝毒清对乙型肝炎病毒的体内外抑制作用[J].广州中医药大学学报,2004,21(2):134-136. 被引量:13
  • 2曲建慧,张修礼.ConA性小鼠肝损伤模型的研究及应用[J].肝脏,2001,6(3):180-181. 被引量:25
  • 3Kusters S, Tiegs G, Alexopoulou L, et al. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis [ J ]. Eur J Immumol,1997, 27 (11): 2870.
  • 4Gantner F, Leist M, Lohse A W, et al. Concanavalin A induced T cell mediated hepatic injury in mice: the role of tmnor nocrosis factor [J].Hepatology, 1995, 21 (1): 190.
  • 5Trautwein C, Rakemann T, Brenner D A, et al. Concanavalin Ainduced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice [J]. Gastroenterology, 1998, 114(5): 1035.
  • 6Zhao Y, Liu J, Wang J, et al. Fumigaclavine C improves concanavalin A-induced liver injury in mice mainly via inhibiting TNF-alpha production and lymphocyte adhesion to extracellular matrices [ J ]. J Pharm Pharmacol, 2004, 56 (6): 775.
  • 7郑晓宾,韩德五,许瑞龄,赵元昌,马学惠.丹参防治实验性急性肝损伤机制的研究[J].中国免疫学杂志,1997,13(3):157-158. 被引量:31
  • 8米志宝,陈鸿珊,张习坦,李壮,陈万荣,邵兴无.用嗜肝DNA病毒模型筛选抗病毒中草药[J].中国中药杂志,1997,22(1):43-45. 被引量:34
  • 9Singh B, Saxena A K, Chandan B K, et al. In vivo hepatoprotective activity of active fraction from ethanolic extract of Eclipta alba leaves [J]. Indian J Physiol Pharmacol, 2001, 45 (4): 435.
  • 10Saxena A K, Singh B, Anand K K. Hepatoprotective effects of Eclipta alba on subcellular levels in rats [J]. J Ethnopharmacol, 1993 , 40(3): 155.

二级参考文献24

  • 1韩德五.肝功能衰竭发病机制的研究─—肠源性内毒素血症假说[J].肝脏病杂志,1995,3(3):134-137. 被引量:111
  • 2程书权,卫存贵.促肝细胞生长素在肝炎后肝硬化失代偿期的应用价值(附58例分析)[J].临床荟萃,1996,11(21):978-978. 被引量:4
  • 3张福杰 郭丽珠.免疫肽联合iRNA治疗慢性乙肝的疗效观察[J].中华实验与临床病毒学杂志,1997,11(3):2-2.
  • 4张修礼 秦一中 等.一氧化氮合酶在T细胞依赖性小鼠肝损害中的表达[J].中华肝脏病杂志,1999,7:122-122.
  • 5Melzer H. Therapie von leberkrankheiten mitornithin-aspartat[J]. Med Klin, 1998,90(10):1541-1545.
  • 6Cutrin C, Menino M J, Otero X, et al. Effect of nifedipine and saden-osyl methinine in the liver of rats treated with CCl4 and ethanol for one month[J]. Life Sciences, 2000,51(1):113-118.
  • 7Moller S, Juul A, Becker U, et al. The acid-labile subunit of the ternary insulin-like growth factor complex in cirrhosis:relation to liver dystunction[J]. Hepatology, 2000,32(3):441-446.
  • 8Ankrah N A, Rikimaru T, Ekuban F A. Decreased cystenine and gluta-thione levels:possible detexminant of liver toxicity risk in ghanaian subjects[J]. J Int Med, 1999,22(3):171-176.
  • 9Iino S. Therapeutic effects of stronger neominophagen C at different doses on chronic hepatitis and liver cirrhosis[J]. Hepatol Res, 2001, 19(1):31-36.
  • 10Dr E, Campoman S, Galleg O. Treatment de las hepatopatias difusas con fraccion antitoxica[J]. Med Ann, 1999,14(1):3-6.

共引文献102

同被引文献46

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部